SEC 13F Intelligence

Cox Capital Mgt LLC / NVSN

Cox Capital Mgt LLC’s Novartis AG Position

Does Cox Capital Mgt LLC own Novartis AG (NVSN)? Not currently — the last reported position was 23.8K shares worth $2M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2022
Shares
23.8K
% of Portfolio
+1.41%
Quarters Held
17
position exited

Position History NVSN

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ3 ’19Q4 ’19: $2MQ1 ’20: $2MQ2 ’20: $2MQ2 ’20Q3 ’20: $2MQ4 ’20: $2MQ1 ’21: $2MQ1 ’21Q2 ’21: $2MQ3 ’21: $2MQ4 ’21: $2MQ4 ’21Q1 ’22: $2MQ2 ’22: $2MQ3 ’22: $2MQ3 ’22Q4 ’22: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202223.8K$2M+1.41%
Q3 202223.7K$2M+1.31%
Q2 202223.5K$2M+1.36%
Q1 202224.0K$2M+1.32%
Q4 202123.9K$2M+1.24%
Q3 202123.4K$2M+1.29%
Q2 202123.4K$2M+1.43%
Q1 202122.4K$2M+1.33%
Q4 202023.0K$2M+1.65%
Q3 202022.1K$2M+1.70%
Q2 202021.4K$2M+1.84%
Q1 202020.0K$2M+1.65%
Q4 201920.0K$2M+1.72%
Q3 201920.2K$2M+1.71%
Q2 201920.5K$2M+1.90%
Q1 201919.6K$2M+2.04%
Q4 201819.5K$2M+1.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cox Capital Mgt LLC’s full portfolio or all institutional holders of NVSN.